Authors:
Yarasheski, KE
Tebas, P
Stanerson, E
Claxton, S
Marin, D
Bae, K
Kennedy, M
Tantisiriwat, W
Powderly, WG
Citation: Ke. Yarasheski et al., Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy, J APP PHYSL, 90(1), 2001, pp. 133-138
Authors:
Tebas, P
Henry, K
Nease, R
Murphy, R
Phair, J
Powderly, WG
Citation: P. Tebas et al., Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapy, AIDS, 15(5), 2001, pp. 591-599
Authors:
Koletar, SL
Heald, AE
Finkelstein, D
Hafner, R
Currier, JS
McCutchan, JA
Vallee, M
Torriani, FJ
Powderly, WG
Fass, RJ
Murphy, RL
Citation: Sl. Koletar et al., A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 X 10(6)/I, AIDS, 15(12), 2001, pp. 1509-1515
Authors:
Fichtenbaum, CJ
Koletar, S
Yiannoutsos, C
Holland, F
Pottage, J
Cohn, SE
Walawander, A
Frame, P
Feinberg, J
Saag, M
Van der Horst, C
Powderly, WG
Citation: Cj. Fichtenbaum et al., Refractory mucosal candidiasis in advanced human immunodeficiency virus infection, CLIN INF D, 30(5), 2000, pp. 749-756
Authors:
Fichtenbaum, CJ
Zackin, R
Rajicic, N
Powderly, WG
Wheat, LJ
Zingman, BS
Citation: Cj. Fichtenbaum et al., Amphotericin B oral suspension for fluconazole-refractory oral candidiasisin persons with HIV infection, AIDS, 14(7), 2000, pp. 845-852
Authors:
Tebas, P
Powderly, WG
Claxton, S
Marin, D
Tantisiriwat, W
Teitelbaum, SL
Yarasheski, KE
Citation: P. Tebas et al., Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy, AIDS, 14(4), 2000, pp. F63-F67
Authors:
Benson, CA
Williams, PL
Cohn, DL
Becker, S
Hojczyk, P
Nevin, T
Korvick, JA
Heifets, L
Child, CC
Lederman, MM
Reichman, RC
Powderly, WG
Notario, GF
Wynne, BA
Hafner, R
Citation: Ca. Benson et al., Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial, J INFEC DIS, 181(4), 2000, pp. 1289-1297
Authors:
Fichtenbaum, CJ
German, M
Dunagan, WC
Fraser, VJ
Medoff, G
Diego, J
Powderly, WG
Citation: Cj. Fichtenbaum et al., A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin B, CLIN INF D, 29(6), 1999, pp. 1551-1556
Authors:
Tantisiriwat, W
Tebas, P
Clifford, DB
Powderly, WG
Fichtenbaum, CJ
Citation: W. Tantisiriwat et al., Progressive multifocal leukoencephalopathy in patients with AIDS receivinghighly active antiretroviral therapy, CLIN INF D, 28(5), 1999, pp. 1152-1154
Citation: Cj. Fichtenbaum et Wg. Powderly, Refractory mucosal candidiasis in patients with human immunodeficiency virus infection - Reply, CLIN INF D, 28(2), 1999, pp. 408-408
Authors:
Powderly, WG
Gallant, JE
Ghannoum, MA
Mayer, KH
Navarro, EE
Perfect, JR
Citation: Wg. Powderly et al., Oropharyngeal candidiasis in patients with HIV: Suggested guidelines for therapy, AIDS RES H, 15(18), 1999, pp. 1619-1623
Citation: Wg. Powderly et al., Diagnosis and treatment of oropharyngeal candidiasis in patients infected with HIV: A critical reassessment, AIDS RES H, 15(16), 1999, pp. 1405-1412
Authors:
Tebas, P
Patick, AK
Kane, EM
Klebert, MK
Simpson, JH
Erice, A
Powderly, WG
Henry, K
Citation: P. Tebas et al., Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavir, AIDS, 13(2), 1999, pp. F23-F28